NeuBase Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

COMMON STOCK WARRANTS (Details Narrative)

COMMON STOCK WARRANTS (Details Narrative) (USD $)	2 Months Ended	12 Months Ended		72 Months Ended		0 Months Ended																								3 Months Ended	12 Months Ended													12 Months Ended		0 Months Ended			12 Months Ended						0 Months Ended	12 Months Ended	0 Months Ended
COMMON STOCK WARRANTS (Details Narrative) (USD $)	Jul. 11, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Mar. 21, 2013	Mar. 21, 2013 Warrants	Dec. 21, 2012 Warrants	Oct. 30, 2012 Warrants	Sep. 07, 2012 Warrants	Jul. 11, 2012 Warrants	Jun. 28, 2012 Warrants	May 18, 2012 Warrants	Apr. 12, 2012 Warrants	Mar. 03, 2012 Warrants	Dec. 16, 2011 Warrants	Aug. 23, 2011 Warrants	Jul. 15, 2011 Warrants	Jun. 13, 2011 Warrants	May 12, 2011 Warrants	Dec. 30, 2010 Warrants	Jul. 23, 2010 Warrants	Apr. 09, 2010 Warrants	Jan. 15, 2010 Warrants	Dec. 04, 2009 Warrants	Nov. 09, 2009 Warrants	Oct. 09, 2009 Warrants	Sep. 30, 2009 Warrants	Jun. 03, 2009 Warrants	Mar. 20, 2009 Warrants	Aug. 23, 2011 Warrants	Sep. 30, 2013 Warrants	Jul. 02, 2013 Warrants	Jun. 14, 2013 Warrants	Jun. 07, 2013 Warrants	Apr. 18, 2013 Warrants	Mar. 27, 2013 Warrants	Mar. 22, 2013 Warrants	Mar. 11, 2013 Warrants	Mar. 07, 2013 Warrants	Oct. 24, 2012 Warrants	Jul. 17, 2012 Warrants	Apr. 10, 2012 Warrants	Dec. 15, 2009 Warrants	Sep. 30, 2013 Warrants Lower Range	Sep. 30, 2013 Warrants Upper Range	Dec. 30, 2010 Class I Warrants	Dec. 16, 2011 Class J Warrants	Apr. 12, 2012 Warrant	Sep. 30, 2013 Warrant	Sep. 30, 2012 Warrant	Sep. 30, 2011 Warrant	Sep. 30, 2010 Warrant	Sep. 30, 2009 Warrant	Sep. 30, 2008 Warrant	Jun. 28, 2012 Replacement Warrants	Sep. 30, 2013 Replacement Warrants	Apr. 18, 2013 Series B warrants
Fair Value assumptions:
Stock price at valuation																																												$ 0.63	$ 4.32
Expected term																																												3 years	5 years
Exercise Price																																												$ 1.50	$ 4.32
Risk free interest rate																																												0.21%	2.90%
Dividend yield																																												0.00%	0.00%
Volatility rate																																												114.00%	276.00%
Warrants date issued																																														Dec. 10, 2010	Dec. 16, 2011
Warrants, issued	133,333					56,667	1,042	3,995,122	25,000	16,667	1,059,803	116,667	5,000	116,667	305,559	16,667	33,333	100,000	18,333	840,000	31,000	3,333	1,861,112	43,333	6,000	29,333	50,000	3,722,224	1,666,667	208,333	208,333															840,000	305,559	5,000							1,059,803		2,253,531
Proceeds from issuance of warrants																																														$ 1,050,000	$ 1,100,000
Exercise price, warrant						4.32	1.95	3.57	3.00	2.85	3.60	2.85	2.70	1.95	1.95	2.01	1.62	1.50	1.50	1.65	1.50	1.65	1.65	1.80	1.50	1.50	1.20	0.54	1.50	2.01	1.95	1.50	1.50	1.65	3.57	1.65	1.65	3.57	3.57	1.50	1.50	1.80	0.54			1.65	1.95		2.77	2.80	2.50	2.66	2.06	3.54		3.60	6.75
Fair value recognized as derivative liability			(768,696)																																											528,847	314,453
Allocation of proceeds to stock																																														521,153	644,077									2,663,204
Consulting Expense, as recorded in professional fees						135,710	1,967		65,978																																								157,235	200,159
Warrants issued for services	357,394	270,167	309,322	599,989		232,374								220,422																	296,882																	12,775									1,414,995
Fair value of warrants issued for services		335,869
Vested warrants					40,000						2,663,204
Warrants, expired																																																									326,597
Intrinsic value of awards		$ 6,620,000		$ 6,620,000																																													$ 3,120,000